Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

About the Cover

December 1, 2016; Volume 57,Issue 12

Cover image

Cover image expansion

225Ac-PSMA-617 has shown high potential to benefit patients with metastatic castration-resistant prostate cancer who are in a clinically critical situation. See page 1941.

Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 57 (12)
Journal of Nuclear Medicine
Vol. 57, Issue 12
December 1, 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Clinically Approved Nanoparticle Imaging Agents
  • In Vivo Imaging of Human 11C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses
  • Quantification of Task-Specific Glucose Metabolism with Constant Infusion of 18F-FDG
  • Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions
Sign up for alerts

Jump to

  • This Month in JNM
  • SNMMI Newsline
  • Editorial
  • Focus on Molecular Imaging
  • Invited Perspectives
  • Clinical Investigations
  • Brief Communications
  • Continuing Education
  • Basic Science Investigations
  • Brief Communications
  • Special Contributions
  • Book Reviews
  • Letters to the Editor
  • Most Cited
  • Most Read
Loading
  • 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers
  • 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
  • First Human Imaging Studies with the EXPLORER Total-Body PET Scanner*
  • Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
  • Deep Learning Analysis of Upright-Supine High-Efficiency SPECT Myocardial Perfusion Imaging for Prediction of Obstructive Coronary Artery Disease: A Multicenter Study
More...
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire